Table 2.
Overall N = 46 |
≤ 40 years N = 28 |
> 40 years N = 18 |
P value | Males N = 31 |
Females N = 15 |
P value | |
---|---|---|---|---|---|---|---|
LQTS | 1 (2.2%) | 0 | 1 (5.6%) | NS | 0 | 1 (6.7%) | NS |
CPVT | 5 (10.9%) | 5 (17.9%) | 0 | NS | 3 (9.7%) | 2 (13.3%) | NS |
Borderline CPVT | 1 (2.2%) | 0 | 1 (5.6%) | NS | 1 (3.2%) | 0 | NS |
ACM | 6 (13.0%) | 2 (7.1%) | 4 (22.2%) | NS | 6 (19.4%) | 0 | NS |
BrS | 2 (4.3%) | 1 (3.6%) | 1 (5.6%) | NS | 2 (6.5%) | 0 | NS |
Other | 3 (6.5%) | 2 (7.1%) | 1 (5.6%) | NS | 0 | 3 (20.0%) | 0.01 |
Final diagnosis | 17 (37.0%) | 10 (35.7%) | 7 (38.9%) | NS | 11 (35.5%) | 6 (40.0%) | NS |
Incomplete follow-up | 21 (45.6%) | 14 (50.0%) | 7 (38.9%) | NS | 15 (48.4%) | 6 (40.0%) | NS |
True idiopathic VF | 7 (15.2%) | 4 (14.3%) | 3 (16.7%) | NS | 4 (12.9%) | 3 (20.0%) | NS |
NS no significance, VF ventricular fibrillation, LQTS long QT syndrome, CPVT catecholaminergic polymorphic ventricular tachycardia, ACM arrhythmic cardiomyopathy, BrS Brugada syndrome.